Deciphering the late steps of rifamycin biosynthesis.
Qi, F., Lei, C., Li, F., Zhang, X., Wang, J., Zhang, W., Fan, Z., Li, W., Tang, G.L., Xiao, Y., Zhao, G., Li, S.(2018) Nat Commun 9: 2342-2342
- PubMed: 29904078 
- DOI: 10.1038/s41467-018-04772-x
- Primary Citation of Related Structures:  
5YSM, 5YSW - PubMed Abstract: 
Rifamycin-derived drugs, including rifampin, rifabutin, rifapentine, and rifaximin, have long been used as first-line therapies for the treatment of tuberculosis and other deadly infections. However, the late steps leading to the biosynthesis of the industrially important rifamycin SV and B remain largely unknown ...